RSVI-303

N/A

Report date: 2025/09/05 17:15:22
NME

Base Information

Drug NameRSVI-303
Drug Alias NameRSVI-303
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionKrueppel-like factor 11 modulators
TargetsKrueppel-like factor 11
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRosVivo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRosVivo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A